Treatment Free Remission in CML

Mohiuddin Ahmed Khan(1)
(1) Dhaka Medical College, Dhaka, Bangladesh

Full text article

Generated from XML file

References

Goldman J, Gordon M. Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: does it really matter?. Leukemia & lymphoma. 2006 Jan 1;47(1):1-7. doi: 10.1080/10428190500407996.

Hochhaus A, Baccarani M, Silver RT, Schiffer C, Apperley JF, Cervantes F, Clark RE, Cortes JE, Deininger MW, Guilhot F, Hjorth-Hansen H. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia. 2020 Apr;34(4):966-84. doi: 10.1038/s41375-020-0776-2.

Etienne G, Guilhot J, Rea D, Rigal-Huguet F, Nicolini F, Charbonnier A, Guerci-Bresler A, Legros L, Varet B, Gardembas M, Dubruille V. Long-term follow-up of the French Stop Imatinib (STIM1) study in patients with chronic myeloid leukemia. Journal of Clinical Oncology. 2017 Jan 20;35(3):298-305. doi: 10.1200/JCO.2016.68.2914.

Kadowaki N, Kawaguchi T, Kuroda J, Nakamae H, Matsumura I, Miyamoto T, Ishikawa J, Nagafuji K, Imamura Y, Yamazaki H, Shimokawa M. Discontinuation of nilotinib in patients with chronic myeloid leukemia who have maintained deep molecular responses for at least 2 years: a multicenter phase 2 stop nilotinib (Nilst) trial. Blood (ASH Annual Meeting Abstracts) 2016; 128(Suppl):790. doi: 10.1182/blood.V128.22.790.790.

Hochhaus A, Masszi T, Giles FJ, Radich JP, Ross DM, Gomez Casares MT, Hellmann A, Stentoft J, Conneally E, Garcia-Gutierrez V, Gattermann N. Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study. Leukemia. 2017 Jul;31(7):1525-31. doi: 10.1038/leu.2017.63.

Deininger MW, Shah NP, Altman JK, et al. Chronic myeloid leukaemia, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18:1385–415. doi: 10.6004/jnccn.2020.0047.

Leukaemia & Lymphoma Society, https://www.lls.org/sites/default/files/2021-05/FS34_Treatment_Free_Remission2018.

Saussele S, Richter J, Hochhaus A, Mahon FX. The concept of treatment-free remission in chronic myeloid leukemia. Leukemia. 2016 Aug;30(8):1638-47. doi: 10.1038/leu.2016.115

Authors

Mohiuddin Ahmed Khan
dr.khan59@gmail.com (Primary Contact)
Author Biography

Mohiuddin Ahmed Khan, Dhaka Medical College, Dhaka

Ex Professor and Head of Haematology, Dhaka Medical College

1.
Khan MA. Treatment Free Remission in CML. Haematol J Bangladesh [Internet]. 2024 Feb. 20 [cited 2024 Apr. 17];8(1):1-2. Available from: https://journal.hematologybd.org/index.php/haematoljbd/article/view/126

Article Details

How to Cite

1.
Khan MA. Treatment Free Remission in CML. Haematol J Bangladesh [Internet]. 2024 Feb. 20 [cited 2024 Apr. 17];8(1):1-2. Available from: https://journal.hematologybd.org/index.php/haematoljbd/article/view/126